
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW292565 |
disease
Virulence Pathway (virH operon activation)Agrobacterium tumefaciens str. C58
The virH operon is part of the broader virulence (vir) regulon that is essential for a bacterium's ability to transfer T-DNA to plant cells, causing crown gall disease. The virulence genes are typically located on the Ti (tumor-inducing) plasmid, and their expression is regulated in response to plant-derived signals. The bicistronic virH operon is composed of 2 genes - virH1 and virH2 whose proteins resemble those of the cytochrome P450-type mono-oxygenases family. Expression of this operon is induced by phenolic compounds e.g., acetosyringone (AS) and repressed by indole acetic acid (IAA) which acts as a competitive inhibitor of AS. This expression is controlled by virA which encodes for a transmembrane histidine protein kinase and virG which encodes a cytoplasmic response regulator. AS binds to transmembrane histidine protein kinase virA, resulting in phosphorylation of virG which then binds to the vir box (10 to 12bp sequences) in the promoter region and initiates transcription. VirH2 is reponsible for a O-demethylation reaction which converts ferulic acid (a plant phenolic defence compound) to caffeic acid, which is less toxic, thus facilitating pathogenicity. VirH1, sharing 20% identitiy to virH2, is also involved in metabolism of phenolic compounds, though different from those metabolized by virH2.
|
Creator: Julia Wakoli Created On: August 27, 2024 at 17:24 Last Updated: August 27, 2024 at 17:24 |
PW091256 |
Visceral Fat Deposits and the Metabolic SyndromeHomo sapiens
Although abdominal obesity or visceral obesity is considered to be one of the components of metabolic syndrome and to have an important role in a cluster of cardiovascular risks, there is no consensus about the definition and diagnostic criteria for this syndrome, probably because there is considerable disagreement about the location and definition of abdominal obesity or visceral obesity. The importance of diagnosing metabolic syndrome, in which visceral fat accumulation plays an essential role in the development of multiple risk factors, should be emphasized because lifestyle modification for the reduction of visceral fat may be very effective for the reduction of risks of this type, namely metabolic syndrome in the narrow sense.
|
Creator: Aidin Foroutannaddafi Created On: August 14, 2018 at 18:23 Last Updated: August 14, 2018 at 18:23 |
PW132533 |
Vismodegib Drug MetabolismHomo sapiens
Vismodegib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Vismodegib passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 22:17 Last Updated: September 21, 2023 at 22:17 |
PW145850 |
drug action
Vismodegib Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:49 Last Updated: October 07, 2023 at 16:49 |
PW121979 |
disease
Vitamin A DeficiencyRattus norvegicus
Vitamin A deficiency can be caused by many causes. A defect in the BCMO1 gene which codes for beta,beta-carotene 15,15’-monooxygenase is one of them. Beta,beta-carotene 15,15’-monooxygenase catalyzes the chemical reaction where the two substrates are beta-carotene and O2, whereas its product is retinal. A defect in this enzyme results in decrease of levels of retinal and vitamin A in serum; Signs and symptoms include night blindness, poor adaptation to darkness, dry skin and hair.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:51 Last Updated: September 10, 2018 at 15:51 |
PW000210 |
disease
Vitamin A DeficiencyHomo sapiens
Vitamin A deficiency can be caused by many causes. A defect in the BCMO1 gene which codes for beta,beta-carotene 15,15’-monooxygenase is one of them. Beta,beta-carotene 15,15’-monooxygenase catalyzes the chemical reaction where the two substrates are beta-carotene and O2, whereas its product is retinal. A defect in this enzyme results in decrease of levels of retinal and vitamin A in serum; Signs and symptoms include night blindness, poor adaptation to darkness, dry skin and hair.
|
Creator: WishartLab Created On: August 19, 2013 at 12:05 Last Updated: August 19, 2013 at 12:05 |
PW121754 |
disease
Vitamin A DeficiencyMus musculus
Vitamin A deficiency can be caused by many causes. A defect in the BCMO1 gene which codes for beta,beta-carotene 15,15’-monooxygenase is one of them. Beta,beta-carotene 15,15’-monooxygenase catalyzes the chemical reaction where the two substrates are beta-carotene and O2, whereas its product is retinal. A defect in this enzyme results in decrease of levels of retinal and vitamin A in serum; Signs and symptoms include night blindness, poor adaptation to darkness, dry skin and hair.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:49 Last Updated: September 10, 2018 at 15:49 |
PW127355 |
disease
Vitamin A DeficiencyHomo sapiens
Vitamin A deficiency can be caused by many causes. A defect in the BCMO1 gene which codes for beta,beta-carotene 15,15’-monooxygenase is one of them. Beta,beta-carotene 15,15’-monooxygenase catalyzes the chemical reaction where the two substrates are beta-carotene and O2, whereas its product is retinal. A defect in this enzyme results in decrease of levels of retinal and vitamin A in serum; Signs and symptoms include night blindness, poor adaptation to darkness, dry skin and hair.
|
Creator: Ray Kruger Created On: December 15, 2022 at 12:27 Last Updated: December 15, 2022 at 12:27 |
PW144298 |
drug action
Vitamin A Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:20 Last Updated: October 07, 2023 at 13:20 |
PW000892 |
Vitamin B1/Thiamine BiosynthesisEscherichia coli (strain K12)
|
Creator: Ana Marcu Created On: May 08, 2015 at 12:02 Last Updated: May 08, 2015 at 12:02 |